Variations within 3'-UTR of  MDM4  gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy

Yang Yang; Wen Gao; Xi Ding; Wen Xu; Di Liu; Bo Su; Yifeng Sun

doi:10.18632/oncotarget.10771

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy

Yang Yang, Wen Gao, Xi Ding, Wen Xu, Di Liu, Bo Su _ and Yifeng Sun

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:16313-16324. https://doi.org/10.18632/oncotarget.10771

Metrics: PDF 1524 views | HTML 2983 views | ?

Abstract

Yang Yang1, Wen Gao1, Xi Ding2, Wen Xu2, Di Liu2, Bo Su2, Yifeng Sun1

1Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P.R. China

2Central Laboratory, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, P.R. China

Correspondence to:

Bo Su, email: [email protected]

Yifeng Sun, email: [email protected]

Keywords: chemotherapy, non-small cell lung cancer, MDM4, platinum, single nucleotide polymorphisms

Received: March 05, 2016 Accepted: June 17, 2016 Published: July 22, 2016

ABSTRACT

Single-nucleotide polymorphism (SNPs) in microRNA (miRNA)-binding sites may modulate the posttranscriptional regulation of gene expression and explain individual sensitivity to platinum agents. This study aimed to investigate the impact of SNPs located at 3’-untranslated region (UTR) of MDM4 gene, on clinical outcomes of advanced non-small cell lung cancer (NSCLC) patients. Four SNPs were genotyped by using DNA from blood samples of advanced NSCLC patients (642 in the Discovery set and 330 in the Replication set) and were analyzed the relationships with clinical outcomes. Carriers with rs10900598 CC genotype and rs4245739 AC genotype showed increased overall survival (OS) than those with AA genotype (P = 0.017 and P = 0.037, respectively) in the Discovery set and after pooling results from the Replication set. A combined effect on survival of variant alleles was also concluded and validated. Stratification analysis revealed that the effect of MDM4 SNPs was more pronounced in lung adenocarcinoma (LAC) subgroups. A reduced expression of the reporter gene for the C allele of rs4245739 was observed in NSCLC cells using luciferase reporter gene assays. Taken together, our results demonstrate that genetic variations in 3’-UTR of MDM4 gene may influence outcomes of advanced NSCLC by miRNAs-mediated regulation.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10771

Publication Alerts

Research Papers:

Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy

Abstract